Group items tagged

Since 2010, insurance companies had been turned essentially into public utilities with the feds setting strict minimum benefits requirements. The health reform bill also limited the administrative costs of insurers, which has ended up basically guaranteeing their profits. With competition all but outlawed, the increasingly consolidated insurance industry has had very little incentive to pay for new treatment regimens outside those specified by government standard-setting agencies. Federal government health agencies have been reluctant to authorize newer treatments because they often lead to higher insurance premiums that then must be subsidized by higher taxes. The seen aspect of health care reform is that it has had some success in providing more Americans with access to vintage 2010 medical therapies. The unseen aspect is that more people are suffering from and dying of diseases that might well have been cured had the Obama version of health care reform never been enacted. As a result of health care reform, Americans forfeited 2020 medicine in favor of more equal access to 2010 treatments.

Elias Konstantopoulus runs through an optics test with his "bionic" eye glasses during a session at the Lions Vision Research and Rehabilation Center at Johns Hopkins University in Baltimore, Maryland. Konstantopoulus is blind but working with Johns Hopkins University he has been implanted with a microchip and given a set of glasses that enable him to distinguish between light and dark.